Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Exp Clin Psychopharmacol

ISSN 1064-1297; 1936-2293;

2 papers in the library · 198 citations · publishing 2016-2018

Papers

Clinical applications of hallucinogens: A review.

Exp Clin Psychopharmacol August 1, 2016 Albert Garcia‐romeu, Brennan Kersgaard, Peter H. Addy 198 citations

Hallucinogens are grouped into classes—psychedelics, entactogens, dissociatives, and others—based on how they work in the brain and their chemical structure. While these classes have different primary mechanisms, they all can temporarily and profoundly change consciousness, affecting body sensations, perception, thinking, and emotions. These effects likely explain their recreational use, but a growing body of evidence suggests therapeutic applications beyond abuse potential. This review covers data on several hallucinogen classes, focusing on psychedelics, entactogens, and dissociatives, where clinical utility is best documented. It traces historical insights, compares classes from molecular to behavioral levels, and presents up-to-date clinical research with implications for therapeutic value.

Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients.

Exp Clin Psychopharmacol September 27, 2018

Among chronic pain patients, mindfulness is associated with reduced opioid craving, and this relationship is mediated by both autonomic and affective factors. Higher trait mindfulness predicted lower craving through lower sympathetic arousal and less negative affect. The findings suggest that mindfulness may reduce craving by dampening physiological stress responses and improving emotional regulation.